Fair Value Measurements - Contingent Consideration (Details) - USD ($) $ in Thousands |
6 Months Ended | ||||
---|---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2023 |
Jun. 21, 2023 |
Dec. 31, 2022 |
Feb. 25, 2019 |
|
Fair Value Measurements | |||||
Changes in estimated fair value of contingent consideration | $ 75 | ||||
Contingent consideration under RPAs, AAAs and CPPAs | $ 1,000 | 1,000 | $ 75 | ||
Bioasis | Royalty Purchase Agreement | |||||
Fair Value Measurements | |||||
Contingent consideration under RPAs, AAAs and CPPAs | 0 | 0 | $ 75 | ||
LadRx | |||||
Fair Value Measurements | |||||
Changes in estimated fair value of contingent consideration | $ 0 | ||||
Contingent consideration under RPAs, AAAs and CPPAs | $ 1,000 | ||||
LadRx | Royalty Purchase Agreement | |||||
Fair Value Measurements | |||||
Changes in estimated fair value of contingent consideration | $ 0 | ||||
Contingent consideration under RPAs, AAAs and CPPAs | $ 1,000 |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Changes in estimated fair value of contingent consideration. No definition available.
|
X | ||||||||||
- Definition Liability recorded for contingent consideration under purchase agreements. May include royalty purchase agreements, commercial payment purchase agreements, payment interest purchase agreements and assignment and assumption agreements No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|